← Back to headlines
Aclaris Therapeutics, Inc. Bullish Outlook from Stifel
Aclaris Therapeutics, Inc. is identified as a top penny stock in investors' portfolios, with Stifel expressing a bullish outlook on the company's prospects.
7 Jun, 17:59 — 7 Jun, 17:59
Sources
Showing 1 of 1 sources
